BioSig Tech. (BSGM) & Electrophysiology Sector - BioSig to receive 15 units of its PURE EPô System for Limited Market Release - BioSig Tech. (BSGM) & Electrophysiology Sector - InvestorVillage
BioSig Tech. (BSGM) & Electrophysiology Sector
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: BioSig Tech. (BSGM) & Electrophysiology Sector   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  207 of 348  at  7/15/2019 8:05:38 AM  by

CHM_760


BioSig to receive 15 units of its PURE EPô System for Limited Market Release

Westport, CT, July 15, 2019 (GLOBE NEWSWIRE) --

    New units to be prepped for next phase of targeted commercial launch strategy
    Company includes 3 additional hospitals to its list of medical institutions for delivery in 2019 to demonstrate the technology
    Proprietary device is designed to record and display high-fidelity cardiac signals with enhanced visualizations tools

BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it will be receiving 15 units of its PURE EP™ System from its manufacturer in preparation for the Company’s limited market release later this month.

BioSig recently added 3 hospitals, including two distinguished academic centers, to its list of medical institutions that have agreed to receive the device in 2019 to evaluate the PURE EP™ System. These new units, which are being provided at BioSig’s expense on a short term basis, will be used for a series of short- and long-term (up to 180 days) external evaluation studies, which form an essential part of a targeted commercial launch. Currently, management is engaged with other facilities throughout the country. These initial shipments are part of the Company’s stated plans following the recent successful completion of initial clinical cases at the Texas Cardiac Arrhythmia Institute in Austin, TX, Greenville Memorial Hospital in Greenville, SC and Indiana University School of Medicine.

“We are extremely pleased to be on track and schedule with the initial installments of our technology, as we move into the commercialization phase of our strategic business model,” stated Mr. Kenneth L. Londoner, Founder, Chairman and CEO of BioSig Technologies, Inc. “The feedback from hospitals, clinics and physicians has been very encouraging.  We have been actively adding to our clinical, commercial, engineering and operational teams in anticipation of the expansion of working with leading medical centers in the U.S. We look forward to initiating commercialization as we establish ourselves as a market innovator in the medical technology sector.”

PURE EP™ System is an FDA approved proprietary signal acquisition and processing technology. The device is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The device aims to minimize noise and artifacts and acquire high-fidelity cardiac signals. Improving fidelity of acquired cardiac signals may potentially increase the diagnostic value of these signals, thereby possibly improving accuracy and efficiency of the EP studies and related procedures.

BioSig recently announced that it has been added to the Russell 3000 Index and was allowed 33 patent claims covering its PURE EP™ System.
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 388
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
208 Re: BioSig to receive 15 units of its PURE EPô System for Limited Market Release biobullnj 1 7/15/2019 10:46:32 AM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...